From Target Discovery to Clinical Translation: The Development of RES-010

Riccardo is co-founder and CSO of Resalis. He serves as Associate Professor at the Center for RNA Medicine, in the Department of Clinical Medicine of Aalborg University. His research activities are focused on exploring the contribution of non-coding RNA, specifically microRNA, to human metabolism and cancer progression. His aim is to develop new RNA based therapies for unmet medical needs.

Before joining Aalborg University, Riccardo carried on his research activities at Beth Israel Deaconess Medical Center, part of the Harvard Medical School, where he developed and characterized several genetic engineered mouse models and executed a vast plethora of pre-clinical in-vivo experiments designed to optimize new therapeutic paradigm for metabolic disfunctions. Riccardo is part of an international research group led by Prof Kauppinen to develop new therapeutic approaches in the MASH/MAFLD space.